Archives

by in
Entry Author Date Location
Roche To Pay $8.3B For Intermune: Who’s Next In Pulmonary Fibrosis? 08/25/14 San Francisco
Promedior Sees Hope in Small Myelofibrosis Study 05/30/14 Boston
Michigan Life Sciences Roundup: Swift Biosciences, Aastrom 03/11/13 Detroit
Promedior Joins Ranks of Woman-Helmed Biotechs in Massachusetts 12/19/12 Boston
Promedior, Aveo, Ra, and More Boston Life Sciences Headlines 05/18/12 Boston
Promedior Moves Fibrosis Pipeline to Boston, Hires Shire Vet as CEO 05/15/12 Boston
Page 1 of 1